Saturday, May 9, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle

"icmr"

  • Why a heart attack in Hyderabad is a direct ticket to poverty

    A new ICMR-funded study involving NIMS reveals that rising heart failure treatment costs are pushing many Hyderabad families into poverty. Lack of insurance, costly medicines, income loss, and distress financing are leaving households burdened with severe financial stress after cardiac illnesses.
  • No end in sight: Telangana struggles with dog bite surge and anti-rabies vaccine shortage

    Telangana continues to grapple with a rising dog bite crisis, with Hyderabad and surrounding districts reporting 3,500-3,800 new cases every month. While anti-rabies vaccines are available, a severe shortage of Rabies Immunoglobulin (RIG) has left victims vulnerable, especially those with severe Category-III bites.
  • Made-in-India TB diagnostic tests validated by ICMR; offer cheaper, faster detection

    ICMR has validated two new TB diagnostic tools—Quantiplus MTB FAST and UniAMP MTB Test Card—developed by Huwel Lifesciences. These affordable, scalable, and non-invasive innovations aim to revolutionize early TB detection, especially in underserved areas, supporting India’s TB elimination goals
  • Hyderabad to lead production of India’s first indigenous malaria vaccine

    India’s first indigenous malaria vaccine, AdFalci Vax, is set to be produced in Hyderabad after ICMR licensed Indian Immunologicals and Biological E. The multi-stage recombinant vaccine targets malaria at different stages, has shown strong pre-clinical results, and requires only one shot
  • Hyderabad’s AIIMS Bibinagar leads final trials for India’s first indigenous dengue vaccine

    Hyderabad’s AIIMS Bibinagar has emerged as a crucial site for India’s first indigenous dengue vaccine, currently in phase III clinical trials. Led by ICMR and developed in partnership with Panacea Biotec, the single-shot tetravalent vaccine is in its final phase of enrollment.
  • Hyderabad sperm bank raided, seven detained

    Hyderabad police raided a private sperm bank in Secunderabad on Saturday over serious alleged irregularities, including unlicensed surrogacy procedures and unethical collection methods. Seven individuals were detained, and 16 sperm samples were seized.
  • ‘Oil and sugar boards’ now coming up at all govt offices, hospitals, public spaces and more

    Oil and sugar boards showing calorie content in common food items will soon be installed in government offices, hospitals, airports and railway stations. The NIN-led initiative aims to raise public awareness on healthy eating and reduce lifestyle diseases
  • Siddaramaiah’s remarks on Covid vaccines factually incorrect, misleading: Biocon chief Kiran Mazumdar-Shaw

    Karnataka Chief Minister has said the recent heart attack deaths in Hassan district may be linked to the vaccination drive. He also claimed the vaccines were 'hastily' approved
  • Editorial: Be vigilant but don’t panic

    There is a need to focus on ramping up surveillance under the Integrated Disease Surveillance Programme, intensifying genome sequencing and making testing accessible again
  • NIN led consortium advocates for additional health tax on sugary drinks, salty foods

    The consortium, titled ‘Let’s Fix Our Food’ and led by NIN, recommended additional health tax of 20 percent to 30 percent on sweets and confectionaries, health tax of 32 percent on SSBs and HFSS. The group recently submitted its report to ICMR and NITI Aayog.
  • Applications open for PhD courses in scientific institutions affiliated to CSIR, ICMR and DST 

    As part of AcSIR PhD programme, the course is being offered across many disciplines in STEM, in scientific institutes that are affiliated to CSIR, ICMR and DST across India
  • 11 HMPV positive cases were reported in Hyderabad in December 2024

    A private laboratory in Hyderabad disclosed they had in fact detected 11 HMPV positive infections last month
  • 2 children test positive for HMPV in Nagpur

    The children were initially suspected to be infected with H1N1 (swine flu), but later polymerase chain reaction (PCR) tests confirmed HMPV. Both children recovered through outpatient care
  • HMPV: Symptoms, how it spreads and precautions you should take

    Currently, there is no specific antiviral therapy and vaccine to treat HMPV
  • HMPV infection is in circulation globally, including India, ICMR clarifies

    ICMR clarified that, according to current data from the Integrated Disease Surveillance Programme (IDSP) network, there has been no significant increase in cases of Influenza-Like Illness (ILI) or Severe Acute Respiratory Illness (SARI) across the country.
  • Well-prepared to handle respiratory illnesses, no unusual surge: Centre on HMPV scare

    Number of laboratories to be enhanced, Indian Council of Medical Research to monitor trends all year
  • ICMR, Zydus tie up for phase 2 trials of Desidustat in sickle cell disease

    The ICMR has formalized a Memorandum of Agreement (MoA) with Zydus for a Phase IIa double-blind, randomized, placebo-controlled study to assess the efficacy and safety of the oral tablet Desidustat for treating sickle cell disease, a genetic blood disorder marked by abnormal hemoglobin (Hb).
  • ICMR to advance first-in-human trials for zika, flu vaccine, and blood cancers with industry partners

    “The initiative is a key step in positioning India as a leader in the clinical development of pharmaceutical agents,” said the Ministry of Health and Family Welfare. ICMR has formalized Memorandums of Agreement (MoAs) with several sponsors for four promising molecules under its Phase 1 clinical trials network.
  • India working on developing vaccine for dengue

    While development of a dengue vaccine has been perennially in the making, the recent launch of the third phase of clinical trials of dengue vaccine in India by ICMR with Panacea Biotec, has raised hopes over the availability of a dengue vaccine to the general public in the next few years.
  • Doc-talk: Consult the doctor first, before Googling, says Dr. Sainath, Oncologist of Star Hospitals

    Speaking to Telangana Today, senior consultant and Head-Medical Oncologist at Star Hospitals, Dr. Sainath Bhethanabhotla, said patients tend to search their symptoms, rather than their disease or learning about the root-cause of the problem.
1 2 3 … 8 »

Latest News

  • SC to hear PIL seeking regulation of religious schools for children

    7 mins ago
  • Mann says BJP playing ‘dangerous games’ with Punjab amid ED action

    11 mins ago
  • PM Modi to dedicate Rs 1,535 crore railway projects in Telangana during Hyderabad visit

    13 mins ago
  • Cyberabad police holds coordination meeting with bankers to curb rising cybercrime losses

    14 mins ago
  • Hyderabad: Traffic restrictions announced ahead of PM Modi’s visit to Parade Grounds

    13 mins ago
  • Sobhita Dhulipala’s viral comment on authenticity and self-trust wins praise online

    48 mins ago
  • Tamil Nadu Congress MLAs camp in Hyderabad amid government formation uncertainty

    57 mins ago
  • Nora Fatehi to perform at FIFA World Cup 2026 opening ceremony in Toronto

    1 hour ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam